Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3792669rdf:typepubmed:Citationlld:pubmed
pubmed-article:3792669lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3792669lifeskim:mentionsumls-concept:C0019638lld:lifeskim
pubmed-article:3792669lifeskim:mentionsumls-concept:C0026724lld:lifeskim
pubmed-article:3792669lifeskim:mentionsumls-concept:C0013295lld:lifeskim
pubmed-article:3792669lifeskim:mentionsumls-concept:C0043515lld:lifeskim
pubmed-article:3792669lifeskim:mentionsumls-concept:C0683278lld:lifeskim
pubmed-article:3792669pubmed:dateCreated1987-2-19lld:pubmed
pubmed-article:3792669pubmed:abstractTextEndoscopic biopsies were taken from the oxyntic mucosa in patients with duodenal ulcer (DU) before and after 4 weeks of treatment with omeprazole. Biopsies were also obtained from Zollinger-Ellison (ZE) patients before and during treatment with omeprazole; these patients had previously failed to respond to other therapies aiming at reducing gastric acid secretion. Healthy volunteers served as controls. Light-microscopic studies of biopsy sections revealed superficial gastritis in most of the patients. Endocrine cell volume density (that is, the percentage of mucosal volume occupied by endocrine cells) was 0.3% in the DU patients and 0.7% in the ZE patients before omeprazole treatment. No significant change occurred during omeprazole treatment, which in the ZE patients continued for up to 21 months. In the controls, 0.3% of the mucosal volume was occupied by endocrine cells. Parietal cell volume density was about 15% in both the DU patients and in the controls; in the ZE patients, slightly but not significantly higher values were recorded. No significant change was observed during omeprazole treatment.lld:pubmed
pubmed-article:3792669pubmed:languageenglld:pubmed
pubmed-article:3792669pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3792669pubmed:citationSubsetIMlld:pubmed
pubmed-article:3792669pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3792669pubmed:statusMEDLINElld:pubmed
pubmed-article:3792669pubmed:issn0012-2823lld:pubmed
pubmed-article:3792669pubmed:authorpubmed-author:HelanderH FHFlld:pubmed
pubmed-article:3792669pubmed:issnTypePrintlld:pubmed
pubmed-article:3792669pubmed:volume35 Suppl 1lld:pubmed
pubmed-article:3792669pubmed:ownerNLMlld:pubmed
pubmed-article:3792669pubmed:authorsCompleteYlld:pubmed
pubmed-article:3792669pubmed:pagination123-9lld:pubmed
pubmed-article:3792669pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:meshHeadingpubmed-meshheading:3792669-...lld:pubmed
pubmed-article:3792669pubmed:year1986lld:pubmed
pubmed-article:3792669pubmed:articleTitleOxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome.lld:pubmed
pubmed-article:3792669pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3792669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3792669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3792669lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3792669lld:pubmed